KEPIVANCE 5.16 mg/1.2mL
palifermin · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Swedish Orphan Biovitrum AB (publ)
KEPIVANCE is a injection, powder, lyophilized, for solution containing palifermin at 5.16 mg/1.2mL, taken intravenous. Manufactured by Swedish Orphan Biovitrum AB (publ).
Key Facts
- Brand Name
- KEPIVANCE
- Generic Name
- palifermin
- NDC Code (Product)
66658-113- Manufacturer
- Swedish Orphan Biovitrum AB (publ)
- Strength
- 5.16 mg/1.2mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125103
- Drug Class
- Mucocutaneous Epithelial Cell Growth Factor [EPC]
- Marketing Start
- 08/04/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is KEPIVANCE used for?
KEPIVANCE contains palifermin. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is KEPIVANCE a controlled substance?
KEPIVANCE is not classified as a controlled substance by the DEA.
What is the generic name for KEPIVANCE?
The generic name for KEPIVANCE is palifermin. There are no other listed brand versions of palifermin.
What is the NDC code for KEPIVANCE 5.16 mg/1.2mL?
The NDC (National Drug Code) for KEPIVANCE 5.16 mg/1.2mL is 66658-113, listed by Swedish Orphan Biovitrum AB (publ).
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)